The kidneys are the principal organs for excreting water-soluble substances. The biliary system contributes to excretion to the degree that drug is not reabsorbed from the GI tract. Generally, the contribution of intestine, saliva, sweat, breast milk, and lungs to excretion is small, except for exhalation of volatile anesthetics. Excretion via breast milk may affect the breastfeeding infant (see Table 4: Approach to the Care of Normal Infants and Children: Some Drugs Contraindicated for Breastfeeding Mothers).

Hepatic metabolism often increases drug polarity and water solubility. The resulting metabolites are then more readily excreted.

Renal excretion: Renal filtration accounts for most drug excretion. About one fifth of the plasma reaching the glomerulus is filtered through pores in the glomerular endothelium; nearly all water and most electrolytes are passively and actively reabsorbed from the renal tubules back into the circulation. However, polar compounds, which account for most drug metabolites, cannot diffuse back into the circulation and are excreted unless a specific transport mechanism exists for their reabsorption (eg, as for glucose, ascorbic acid, and B vitamins). With aging, renal drug excretion decreases (see Drug Therapy in the Elderly: Renal elimination; see Table 1: Drug Therapy in the Elderly: Effect of Aging on Drug Metabolism* and Elimination); at age 80, clearance is typically reduced to half of what it was at age 30.

The principles of transmembrane passage govern renal handling of drugs. Drugs bound to plasma proteins remain in the circulation; only unbound drug is contained in the glomerular filtrate. Un-ionized forms of drugs and their metabolites tend to be reabsorbed readily from tubular fluids.

Urine pH, which varies from 4.5 to 8.0, may markedly affect drug reabsorption and excretion because urine pH determines the ionization state of a weak acid or base (see Pharmacokinetics: Passive diffusion). Acidification of urine increases reabsorption and decreases excretion of weak acids, and, in contrast, decreases reabsorption of weak bases. Alkalinization of urine has the opposite effect. In some cases of overdose, these principles are used to enhance the excretion of weak bases or acids; eg, urine is alkalinized to enhance excretion of acetylsalicylic acid. The extent to which changes in urinary pH alter the rate of drug elimination depends on the contribution of the renal route to total elimination, the polarity of the un-ionized form, and the molecule's degree of ionization.

Active tubular secretion in the proximal tubule is important in the elimination of many drugs. This energy-dependent process may be blocked by metabolic inhibitors. When drug concentration is high, secretory transport can reach an upper limit (transport maximum); each substance has a characteristic transport maximum.

Anions and cations are handled by separate transport mechanisms. Normally, the anion secretory system eliminates metabolites conjugated with glycine, sulfate, or glucuronic acid. Anions compete with each other for secretion. This competition can be used therapeutically; eg, probenecidSome Trade Names
No US trade name
Click for Drug Monograph
blocks the normally rapid tubular secretion of penicillin, resulting in higher plasma penicillin concentrations for a longer time. In the cation transport system, cations or organic bases (eg, pramipexoleSome Trade Names
MIRAPEX
Click for Drug Monograph
, dofetilideSome Trade Names
TIKOSYN
Click for Drug Monograph
) are secreted by the renal tubules; this process can be inhibited by cimetidineSome Trade Names
TAGAMET
Click for Drug Monograph
, trimethoprimSome Trade Names
PROLOPRIM
TRIMPEX
Click for Drug Monograph
, prochlorperazineSome Trade Names
COMPAZINE
Click for Drug Monograph
, megestrolSome Trade Names
MEGACE
Click for Drug Monograph
, or ketoconazoleSome Trade Names
NIZORAL
Click for Drug Monograph
.

Biliary excretion: Some drugs and their metabolites are extensively excreted in bile. Because they are transported across the biliary epithelium against a concentration gradient, active secretory transport is required. When plasma drug concentrations are high, secretory transport may approach an upper limit (transport maximum). Substances with similar physicochemical properties may compete for excretion.

Drugs with a molecular weight of > 300 g/mol and with both polar and lipophilic groups are more likely to be excreted in bile; smaller molecules are generally excreted only in negligible amounts. Conjugation, particularly with glucuronic acid, facilitates biliary excretion.

In the enterohepatic cycle, a drug secreted in bile is reabsorbed into the circulation from the intestine. Biliary excretion eliminates substances from the body only to the extent that enterohepatic cycling is incomplete—when some of the secreted drug is not reabsorbed from the intestine.

Last full review/revision July 2012 by Jennifer Le, PharmD, BCPS-ID

Content last modified July 2012